Target intelligence / Profile preview

Stathmin-like 2 pseudogene

Molecular classification
Other (Pseudogene)
01

Overview

Stathmin-like 2 pseudogene (ENSG00000205625) is a non-functional genomic DNA sequence related to the functional stathmin-like 2 (STMN2) gene, sharing sequence similarity but lacking the capacity to encode a protein due to disabling mutations or truncations[7][3]. Pseudogenes such as this arise via duplication or retrotransposition mechanisms and typically have no direct biological or therapeutic utility, though in rare cases, some pseudogenes are transcribed and may have regulatory roles; there is no evidence that ENSG00000205625 has such activity[3][7]. The canonical protein-coding gene for stathmin-like 2 is ENSG00000104435 (STMN2), not this pseudogene[2][7]. Pseudogenes are generally not considered druggable targets and rarely have direct disease roles unless proven to acquire a regulatory function[3][5]. The parent gene, STMN2, plays roles in microtubule dynamics, neuronal growth, and is associated with neurodegenerative conditions, but this functional significance does not apply to the pseudogene[4][6][7].

Other names
Stathmin 2 pseudogeneSTMN2 pseudogene

Beyond the preview

Go deeper on Stathmin-like 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stathmin-like 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call